MYnd Analytics (NASDAQ:MYND) was downgraded by research analysts at Maxim Group from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday.
Shares of MYnd Analytics (NASDAQ:MYND) opened at $2.54 on Tuesday. MYnd Analytics has a fifty-two week low of $2.10 and a fifty-two week high of $8.25.
In other news, Director John Pappajohn acquired 10,000 shares of the stock in a transaction that occurred on Friday, January 5th. The stock was purchased at an average cost of $3.44 per share, with a total value of $34,400.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Peter Unanue acquired 15,000 shares of the stock in a transaction that occurred on Wednesday, December 6th. The stock was purchased at an average cost of $3.65 per share, with a total value of $54,750.00. The disclosure for this purchase can be found here. 17.81% of the stock is owned by insiders.
TRADEMARK VIOLATION WARNING: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.dispatchtribunal.com/2018/02/15/mynd-analytics-mynd-rating-lowered-to-hold-at-maxim-group.html.
About MYnd Analytics
MYnd Analytics, Inc, formerly CNS Response, Inc, is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and other non-psychotic disorders.
Receive News & Ratings for MYnd Analytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics and related companies with MarketBeat.com's FREE daily email newsletter.